Cargando…

Generation and Characterization of a Diabody Targeting the α(v)β(6) Integrin

The α(v)β(6) integrin is up-regulated in cancer and wound healing but it is not generally expressed in healthy adult tissue. There is increasing evidence that it has a role in cancer progression and will be a useful target for antibody-directed cancer therapies. We report a novel recombinant diabody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kogelberg, Heide, Miranda, Enrique, Burnet, Jerome, Ellison, David, Tolner, Berend, Foster, Julie, Picón, Carmen, Thomas, Gareth J., Meyer, Tim, Marshall, John F., Mather, Stephen J., Chester, Kerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762766/ https://www.ncbi.nlm.nih.gov/pubmed/24023846 http://dx.doi.org/10.1371/journal.pone.0073260

Ejemplares similares

IMAC capture of recombinant protein from unclarified mammalian cell feed streams
por: Kinna, Alexander, et al.
Publicado: (2015)

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging
por: Goldstein, Robert, et al.
Publicado: (2014)

The use of a surface active agent in the protection of a fusion protein during bioprocessing
por: Blas, Peter, et al.
Publicado: (2018)

Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity
por: Mølgaard, K, et al.
Publicado: (2017)

DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents
por: Chooniedass, Shilpa, et al.
Publicado: (2016)

Anti-HER2 imaging agents for breast cancer imaging
por: Tolner, B, et al.
Publicado: (2010)

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.
por: Adams, G. P., et al.
Publicado: (1998)

Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer
por: Cai, Yaxiong, et al.
Publicado: (2017)

Fermentation, Purification, and Tumor Inhibition of a Disulfide-Stabilized Diabody Against Fibroblast Growth Factor-2
por: Zhang, Simin, et al.
Publicado: (2021)

Crystal structures of mono- and bi-specific diabodies and reduction of their structural flexibility by introduction of disulfide bridges at the Fv interface
por: Kim, Jin Hong, et al.
Publicado: (2016)

Distinguishing Between Monomeric scFv and Diabody in Solution Using Light and Small Angle X-ray Scattering
por: Lüdel, Frank, et al.
Publicado: (2019)

Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation
por: Kuwahara, Atsushi, et al.
Publicado: (2020)

Construction of a disulfide‐stabilized diabody against fibroblast growth factor‐2 and the inhibition activity in targeting breast cancer
por: Cai, Yaxiong, et al.
Publicado: (2016)

Structural considerations for functional anti-EGFR × anti-CD3 bispecific diabodies in light of domain order and binding affinity
por: Asano, Ryutaro, et al.
Publicado: (2018)

Cloning and expression of porcine β1,4 N-acetylgalactosaminyl transferase encoding a new xenoreactive antigen
por: Byrne, Guerard W, et al.
Publicado: (2014)

First clinical study of a pegylated diabody (124)I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers
por: Scott, Andrew M., et al.
Publicado: (2020)

Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2
por: Behdani, Mahdi, et al.
Publicado: (2012)

Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats
por: Asano, Ryutaro, et al.
Publicado: (2020)

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy
por: Yuan, Qingyun, et al.
Publicado: (2021)

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells
por: Bühler, P., et al.
Publicado: (2007)

Design and preclinical evaluation of a (99m)Tc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
por: Kampmeier, Florian, et al.
Publicado: (2014)

Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics
por: Asano, Ryutaro, et al.
Publicado: (2014)

Expression of alphav integrins and vitronectin receptor identity in breast cancer cells.
por: Meyer, T., et al.
Publicado: (1998)

Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma
por: Zhang, Jiayi, et al.
Publicado: (2022)

Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics'
por: Schumacher, Felix F., et al.
Publicado: (2013)

Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
por: Steri, Veronica, et al.
Publicado: (2013)

Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model
por: Kasten, Benjamin B., et al.
Publicado: (2021)

Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in Pichia pastoris and Evaluation of Antitumor Activity In Vivo
por: Xiong, Chenghao, et al.
Publicado: (2018)

Author Correction: Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model
por: Kasten, Benjamin B., et al.
Publicado: (2021)

Integrins as Therapeutic Targets: Successes and Cancers
por: Raab-Westphal, Sabine, et al.
Publicado: (2017)

A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
por: Maruani, Antoine, et al.
Publicado: (2015)

The integrins of the urochordate Ciona intestinalis provide novel insights into the molecular evolution of the vertebrate integrin family
por: Ewan, Richard, et al.
Publicado: (2005)

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
por: Mayer, A, et al.
Publicado: (2004)

The role of integrins in TGFβ activation in the tumour stroma
por: Khan, Zareen, et al.
Publicado: (2016)

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5(NULL)-A20
por: Davies, James A., et al.
Publicado: (2021)

The β3‐integrin endothelial adhesome regulates microtubule‐dependent cell migration
por: Atkinson, Samuel J, et al.
Publicado: (2018)

Homogeneous Bispecifics by Disulfide Bridging
por: Hull, Elizabeth A., et al.
Publicado: (2014)

Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization
por: Fielding, Andrew B., et al.
Publicado: (2008)

The integrins
por: Takada, Yoshikazu, et al.
Publicado: (2007)

Integrins
por: Barczyk, Malgorzata, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5n6eiv824v87mfpg8l06sjpp2n